Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

6 days from now

Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. ... January 17th, 2024: Ratio Therapeutics Announces $50M Series …

crunchbase.com

Series B - Ratio Therapeutics - 2024-01-17 - Recent News

6 days from now

Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Fierce Pharma — BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic

crunchbase.com

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

The Week’s 10 Biggest Funding Rounds: Quantinuum

6 days from now

Jan 19, 2024  · Founded in 2021, this is the company’s first round with a disclosed amount, per Crunchbase. 9. Ratio Therapeutics, $50M, biotech: Boston-based Ratio Therapeutics, a …

crunchbase.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. PR Newswire . Wed, Jan 17, 2024, 8:00 AM 3 min read. ... WRD WeRide …

yahoo.com

Ratio Therapeutics Announces $50M Series B Financing To

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio …

biospace.com

News - Ratio Therapeutics

6 days from now

January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical Company …

ratiotx.com

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

On January 17, 2024 Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the …

1stoncology.com

Ratio Therapeutics Scores $50M Series B - VC News Daily

6 days from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

vcnewsdaily.com

Ratio Therapeutics Raises $50M In Series B Financing

6 days from now

Jan 17, 2024  · Ratio Therapeutics Raises $50M in Series B Financing Jan 17, 2024 ... Save for later NEW YORK – Ratio Therapeutics on Wednesday announced that it has raised $50 …

precisionmedicineonline.com

2024 - Ratio Therapeutics

6 days from now

Jun 20, 2024  · January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical …

ratiotx.com

Ratio Therapeutics Raises $50M For Tumor-targeting …

6 days from now

Jan 17, 2024. Listen to this ... Ratio Therapeutics Inc. has secured the backing to move its first drug candidate into clinical trials by the end of this year. ... Ratio announced its $50M Series ...

bizjournals.com

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

6 days from now

Jan 29, 2024  · Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. FoundersX Ventures FoundersX Ventures, a cross-stage venture capital firm based in Menlo Park with …

crunchbase.com

Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase

6 days from now

Oct 3, 2024  · PR Newswire — Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment News • Oct 3, 2024 Research Tree — Syncona Limited - …

crunchbase.com